Company Report | Volume Increases Amid Slowing Covid-19 Cases
Throughout 1H22, MIKA posted a decrease in revenue and net profit of 13.3% YoY and 14.0% YoY, respectively. All segments contracted at 1H22.
Company Report | ICBP’s Performance Amid Higher Volume and Average Selling Price (ASP)
ICBP booked 1H22 sales of IDR32.6 trillion (+15.6% YoY) with the Nutrition and Specialty Foods segment leading the growth at 18.7% YoY.
Company Report | Increases ASP for Some Products
In 2Q22, KLBF posted sales of IDR6.9 trillion led by growth in the Nutrition segment (+9.8% YoY). Meanwhile, cumulatively 1H22 sales were recorded at IDR13.9 trillion (+12.2% YoY).
Company Report | Market Share Stable in 2Q22
During 6M22, HMSP’s top line grew 12.3% YoY to IDR53.5 trillion. The increase in production costs caused gross profit, operating profit, and net profit to contract by 9.7% YoY, 22.8% YoY, and 26.3% YoY, respectively.
Company Report | Performance Overshadowed by Raw Material Price Increases
PIN’s revenue throughout 6M22 grew 12.4% YoY, while net profit declined 14.7% YoY. The increase in raw material prices caused declining profit amid growing revenue.
Company Report | Positive Performance Amid Mobility Recovery in 2Q22
UNVR sales in 2Q22 were recorded at Rp10.6 trillion (+7.4% YoY) driven by an increase in domestic sales (+7.8% YoY) to Rp10.2 trillion.
MAPI – 1Q22 Enthusiasm Amid Social Mobility Relaxation
In 1Q22, MAPI booked a revenue performance growth of 30.6% YoY and net profit significantly jumped to IDR512.8 billion.
MIKA – 1Q22 Performance Supported by Non-Covid19 Patients
MIKA booked 1Q22 revenue of IDR1.1 trillion or down 9.2% compared to the same period last year (vs 1Q21: IDR1.2 trillion) due to declines in the Inpatient and Outpatient segments.
KLBF – Performance Overshadowed by Increasing Raw Material Prices
Distribution and Logistics Segment grew 28.9% YoY in 1Q22, pushing sales in 1Q22 up to IDR7.0 trillion (+16.6% YoY), and net profit of 1Q22 jumped 16.5% YoY to IDR834.9 billion
